Article
NEW YORK — Health care stocks have started off the year on a tear.
The industry group that includes health care providers, drugmakers and biotechnology companies has advanced 7.3 percent this year, making it the second-best in the Standard and Poor’s 500 index, trailing only energy companies. Even drugmakers, traditionally considered a safe-haven play, are outperforming the market.
Read the full story: http://wapo.st/10VtFrS
Source: The Washington Post
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.